FDA Grants Emergency Authorization To Eli Lilly's COVID Treatment

The video discusses a lab-made antibody treatment for mild to moderate COVID-19 patients, designed to mimic the immune response and prevent severe illness. The FDA has authorized its use for high-risk patients. Challenges include manufacturing and distribution, with initial doses going to hospitals. Infusion centers pose risks due to immunosuppressed patients. Distribution is based on local COVID-19 data. The drug is free, but associated services may incur costs for some patients.

What new insight or understanding did you gain from this video?